The postmenopausal period involves significant biological shifts, including hormonal decline and chronic low-grade inflammation. These physiological changes often remodel the gut microbiota, which further influences the gut-brain axis and menopause outcomes such as mood, cognition, and stress responses. Dietary (poly)phenols offer a promising nutritional strategy to modulate these pathways. However, their biological efficacy depends heavily on the gut microbiota's ability to transform them into active metabolites.

Researchers have identified the gut-brain axis as a vital framework for understanding the systemic health of postmenopausal women. This bidirectional communication system links microbial activity to neuroinflammation and intestinal barrier integrity. Microbial metabolites, including short-chain fatty acids and bile acids, can target specific neurotransmitter synthesis pathways. Furthermore, factors like inflammaging and polypharmacy often modify the host's metabolic response to these dietary compounds.

Optimizing the Gut-Brain Axis and Menopause through Nutrition

Precision health strategies now emphasize the importance of interindividual variability in microbial metabolism. For instance, specific "metabotypes" allow some women to produce equol or urolithins more efficiently from dietary sources. These gut-derived metabolites exert distinct biological effects that may alleviate common menopausal symptoms. Consequently, understanding these individual metabolic profiles is essential for developing personalized dietary interventions.

Clinical evidence suggests that the interaction between polyphenols and the gut microbiota can significantly improve quality of life. However, human intervention studies specifically examining these mechanistic interactions in postmenopausal populations remain limited. Physicians should consider how chronic medications and hormonal status reshape the microbial landscape. Moreover, focusing on microbial metabolites and barrier markers will provide better insights into neuroimmune health. Addressing these research gaps will eventually lead to more effective, tailored strategies for postmenopausal care.

Frequently Asked Questions

What is the estrobolome, and why does it matter during menopause?

The estrobolome is a collection of gut bacteria dedicated to metabolizing and recirculating estrogen. During menopause, a decline in estrogen levels can lead to reduced microbial diversity, which may worsen metabolic and cognitive symptoms.

How do dietary polyphenols support brain health?

Polyphenols require gut microbial transformation to produce bioactive metabolites. These metabolites can cross the blood-brain barrier to reduce neuroinflammation, balance redox levels, and support neurotransmitter synthesis.

What are polyphenol-related metabotypes?

Metabotypes categorize individuals based on their specific gut microbiota composition and its ability to produce certain metabolites, such as equol. These profiles help predict how a person will respond to specific dietary polyphenols.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional consultation with a healthcare provider. Refer to the latest local and national guidelines for clinical practice.

References

García-Nicolás M et al. Dietary (poly)phenols, the gut-brain axis, and menopause: a perspective on an overlooked biological crossroad. Food Funct. 2026 Apr 20. doi: 10.1039/d6fo00429f. PMID: 42003490.

Martínez-Nortes ME et al. Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women. Nutrients. 2025;17(11):2142.

University of Roehampton. Polyphenols and Probiotics to Improve Menopausal Symptoms Via the Gut-Brain Axis (SYMPTOGUT). ClinicalTrials.gov ID NCT06333223.